BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 05, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Inherent Health: Post-marketing study data

Interleukin Genetics Inc. (NYSE-A:ILI), Waltham, Mass.
Product: Inherent Health (Weight Management Genetic test)
Business: Diagnostic
Molecular target: NA
Description: Genetic test panel that identifies an individual's genetic tendencies for weight gain
Indication: Identify patients predisposed for weight loss
Endpoint: Weight loss of patients...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >